BIIB vs. GILD
Compare and contrast key facts about Biogen Inc. (BIIB) and Gilead Sciences, Inc. (GILD).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: BIIB or GILD.
Key characteristics
| BIIB | GILD | |
|---|---|---|
| YTD Return | -15.94% | -19.22% |
| 1Y Return | -30.63% | -14.25% |
| 3Y Return (Ann) | -7.08% | 3.74% |
| 5Y Return (Ann) | -1.21% | 3.40% |
| 10Y Return (Ann) | -1.90% | 1.18% |
| Sharpe Ratio | -1.30 | -0.71 |
| Daily Std Dev | 23.18% | 21.54% |
| Max Drawdown | -90.00% | -70.83% |
| Current Drawdown | -50.39% | -28.22% |
Fundamentals
| BIIB | GILD | |
|---|---|---|
| Market Cap | $30.42B | $81.58B |
| EPS | $8.00 | $4.50 |
| PE Ratio | 26.11 | 14.54 |
| PEG Ratio | 6.24 | 0.42 |
| Revenue (TTM) | $9.66B | $27.45B |
| Gross Profit (TTM) | $7.90B | $21.62B |
| EBITDA (TTM) | $2.52B | $12.82B |
Correlation
The correlation between BIIB and GILD is 0.39, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
BIIB vs. GILD - Performance Comparison
In the year-to-date period, BIIB achieves a -15.94% return, which is significantly higher than GILD's -19.22% return. Over the past 10 years, BIIB has underperformed GILD with an annualized return of -1.90%, while GILD has yielded a comparatively higher 1.18% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
BIIB vs. GILD - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Biogen Inc. (BIIB) and Gilead Sciences, Inc. (GILD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
BIIB vs. GILD - Dividend Comparison
BIIB has not paid dividends to shareholders, while GILD's dividend yield for the trailing twelve months is around 4.66%.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
BIIB Biogen Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
GILD Gilead Sciences, Inc. | 4.66% | 3.70% | 3.40% | 3.91% | 4.67% | 3.88% | 3.65% | 2.90% | 2.57% | 1.27% |
Drawdowns
BIIB vs. GILD - Drawdown Comparison
The maximum BIIB drawdown since its inception was -90.00%, which is greater than GILD's maximum drawdown of -70.83%. Use the drawdown chart below to compare losses from any high point for BIIB and GILD. For additional features, visit the drawdowns tool.
Volatility
BIIB vs. GILD - Volatility Comparison
Biogen Inc. (BIIB) has a higher volatility of 8.43% compared to Gilead Sciences, Inc. (GILD) at 4.60%. This indicates that BIIB's price experiences larger fluctuations and is considered to be riskier than GILD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
BIIB vs. GILD - Financials Comparison
This section allows you to compare key financial metrics between Biogen Inc. and Gilead Sciences, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities